Additionally, this study yielded the following notable findings: (i) significant correlations between changes in ALT or γ‐GTP and in triglyceride; and (ii) an ameliorative effect of pemafibrate on insulin resistance without changes in body weight/BMI in patients without diabetes mellitus. Here, GPT is linked to diabetes mellitus.